The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 03, 2023
Filed:
Feb. 13, 2019
Sorbonne Universite, Paris, FR;
Centre National DE LA Recherche Scientifique, Paris, FR;
Institut National DE LA Santé ET DE LA Recherche Médicale, Paris, FR;
Assistance Publique—hôpitaux DE Paris, Paris, FR;
Institut Du Cerveau ET DE LA Moelle Epiniere, Paris, FR;
Universite DE Montpellier, Montpellier, FR;
Ecole Nationale Superieure DE Chimie DE Montpellier, Montpellier, FR;
Chahrazade El Amri, Ermont, FR;
Feryel Soualmia, Saint-Mande, FR;
Nicolas Masurier, Montpellier, FR;
Sabrina Aït Amiri, Montreuil, FR;
Brahim Nait Oumesmar, Paris, FR;
Cyrille Deboux, Mitry Mory, FR;
SARBONNE UNIVERSITE, Paris, FR;
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, Paris, FR;
INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, Paris, FR;
ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS, Paris, FR;
INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE, Paris, FR;
UNIVERSITÉ DE MONTPELLIER, Montpellier, FR;
ECOLE NATIONALE SUPERIEURE DE CHIMIE DE MONTPELLIER, Montpellier, FR;
Abstract
The invention relates to compounds exhibiting kallikrein inhibitory activity, and to compositions comprising at least one of these compounds for use in the treatment of diseases or disorders in which kallikrein activity is dysregulated, particularly neurodegenerative and inflammatory diseases.